Please assess the completion status of the following clinical trial:

Trial Title: Medtronic Reveal LINQ™ In-Office 2 (RIO 2) Study United States

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient is indicated for continuous arrhythmia monitoring with a Reveal LINQ™ Insertable Cardiac Monitor~2. Patient is 18 years of age or older~3. Patient is willing to undergo ICM insertion procedure outside of the cath lab, OR, EP lab setting with only local anesthetic~4. Patient is willing and able to provide consent and authorize the use and disclosure of health information~5. Patient is willing and able to comply with the protocol including the required follow-up~Exclusion Criteria:~1. Patient has unusual thoracic anatomy or scarring at the implant site which may adversely affect the success of the implant procedure~2. Patient has reduced immune function or is otherwise at high risk for infection per physician discretion~3. Current therapy with immunosuppressive agents or chronic steroid use e.g. Prednisone greater than 20mg per day~4. Patient requires hemodialysis~5. Patient with active malignancy or history of chemotherapy or radiation treatment Patient has had a recent (within 30 days) or an active infection including but not limited to pneumonia, urinary tract, cellulitis, or bacteremia.~6. Patient has had major surgery (in the past 6 months)~7. Patient has undergone a procedure which required central venous or intraarterial access (e.g. AF/VT ablation, EP study, coronary angio) within the last 3 months or is scheduled for such a procedure while enrolled in the study.~8. Prior history of surgical infection, prosthetic device infection, or endovascular infection, including endocarditis, in the past 12 months.~9. Patient has a central venous port, an atrio-venous fistula, or a prosthetic valve~10. Patient requires conscious or moderate sedation to receive LINQ™~11. Patient is already implanted with a loop recorder~12. Patient is implanted or indicated for implant with a pacemaker, ICD, CRT device~13. Patient is enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager.~14. Patient's life expectancy is less than 6 months~15. Patient is pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- In office Outside walls of hospital (Type: EXPERIMENTAL): Reveal LINQ insertions will be performed in office setting. The in office setting was defined as a procedure or office room with controlled entry and hard floors outside the walls of the hospital and not an ambulatory surgery center.
- Traditional Hospital Setting (Type: OTHER): Reveal LINQ insertions will be performed in a traditional setting. The traditional hospital setting includes an operating room or electrophysiology laboratory.

Based on this trial design, predict the completion outcome and termination type (if applicable).